Early identification of persistent pain plus holistic interventions cut opioid use
20 Mar 2024
Clinical Result
In a new study, researchers found that a carefully worded, short questionnaire successfully identified people who were most likely to develop chronic pain. These patients were then steered to a more detailed risk stratification and holistic services that led to better outcomes.
For most people, recovering from an injury or surgery might require a short round of painkillers, but for about one in 10 people, pain can trigger protracted and escalating mental, physical and behavioral health problems.
Identifying who is at risk of poor pain outcomes could help steer patients to early interventions that set them on a better course while also reducing the potential for opioid overuse.
Now, a simple way to spot those at risk could be as simple as a two-question survey. In a study among patients at the Duke Integrated Pain and Wellness Program, researchers found that a carefully worded, short questionnaire successfully identified people who were most likely to develop chronic pain. These patients were then steered to a more detailed risk stratification and holistic services that led to better outcomes.
Findings appear March 20 in the New England Journal of Medicine Catalyst.
"Unlike traditional methods that reactively address chronic pain, this approach proactively provides resources to prevent the development of high-impact chronic pain, ensuring the right patient gets the right resources at the right time -- before the problem escalates," said senior author Padma Gulur, M.D., professor in the departments of Anesthesiology and Population Health Sciences at Duke University School of Medicine.
Gulur and colleagues enrolled patients who were referred to Duke's pain and wellness program. Patients were given a two-questions survey that was developed after reviewing studies that identified factors leading to poor pain outcomes:
More than 13,500 patients -- about 12% -- responded yes to both questions and were considered at high risk of poor pain outcomes.
They further stratified participants into high, medium and low risk categories, with those at highest risk offered personalized treatment plans based on their level of need. The range of holistic interventions included close pain management with a pain specialist, referrals to social services for food, housing or transportation needs, and access to behavioral health, physical therapy and nutrition programs.
"The interventions were tailored to meet patients at their current state of pain management and to motivate them toward adopting a more holistic approach," Gulur said. "The guiding principles emphasize that patients are doing as well as they can with the coping skills they have but, with the right support, they can do better."
Of the 432 patients at highest risk of poor pain outcomes who participated in the holistic treatment approach, 224 patients (51%) reduced their morphine dose within 30 days.
The number of patients who reduced their morphine dose rose to 299 patients at 60 days and to 349 patients at 180 days. The program's effects were much better than those achieved through other chronic pain management approaches.
"By demonstrating the effectiveness of early identification and intervention for patients at risk of poor pain outcomes, this research can inform the development of new therapies and treatment approaches focused on prevention," Gulur said. "It could lead to improved health services by integrating similar proactive care models into broader health care settings, enhancing scientific understanding and leading to better health care outcomes through more personalized and preemptive pain management strategies."
In addition to Gulur, study authors include Nathan Christie, Amy Pope, Diana Zambrano, Kevin Vorenkamp, and Amanda Nelli.
The study was funded by Duke Health.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Indications
Targets
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.